Ultrasound with contrast dye for early liver cancer screening
Part of Digestive system clinical trials.
This trial tests whether a special ultrasound scan using contrast dye can better detect early liver cancer in people with cirrhosis (scarring of the liver). The goal is to catch liver cancer at an earlier, more treatable stage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cirrhosis (liver scarring) diagnosed by a doctor or imaging scan
- You are between 18 and 80 years old
- You can attend regular ultrasound and MRI or CT scans as scheduled
- You do not have liver cancer that needs treatment right now
- You can give informed consent to participate
- You do not have severe heart, lung, or kidney problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well ultrasound, standard MRI, and special MRI (with a contrast agent) find liver cancer in people at high risk. You may join if you have certain risk factors like hepatitis B or C, heavy alcohol use, fatty liver, or a family history of liver cancer.
This study aims to improve how doctors diagnose and treat liver cancer by combining advanced imaging tests and genetic analysis. It may help in choosing the most effective treatment for each person.
This trial compares two types of imaging scans (CEUS and AMRI) to see which one is better at finding liver cancer (HCC) in patients who have an unclear spot on their liver (an indeterminate nodule). It is for people with cirrhosis who have at least one such nodule but no confirmed liver cancer yet.
This trial looks at whether special features seen on contrast-enhanced ultrasound can help doctors better classify liver nodules using a system called LI-RADS. It’s for people at high risk for liver cancer who have recent imaging and clear tissue diagnosis.
This trial uses a special ultrasound with contrast dye to get a clearer picture of liver spots that other scans (CT, MRI, or PET) couldn't fully identify. The goal is to see if this ultrasound can help doctors make a more accurate diagnosis.
This study compares a shorter, non-contrast MRI and ultrasound to monitor for liver cancer in people with cirrhosis whose ultrasound images aren’t clear enough. It aims to see which method works better and may help you get safer, more reliable follow-up.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.